# Tiotropium

## Spiriva Respimat 2.5mcg/puff

##### 

| 藥品代碼   | ESPIR                                                                                                                                                                                                                                                                                           |
|:-----------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症     | Maintenance treatment of patients with COPD (including chronic bronchitis & emphysema).                                                                                                                                                                                                         |
| 用法用量   | Adult:Inhale 2 puffs once daily at the same time of day. Age 6-17 years with asthma: 2 puffs once daily at the same time of day. Age <6 years: Limited data available.                                                                                                                          |
| 肝功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                    |
| 腎功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                    |
| 禁忌       | Patients with a history of hypersensitivity to atropine or its derivatives eg， ipratropium or oxitropium， or to any component of Spiriva.                                                                                                                                                     |
| 副作用     | GI disturbances， cough & local irritation， dysuria， urinary retention (in men)， tachycardia， allergic reactions. Gastrointestinal: Constipation (4% )， Xerostomia (12% to 16% ) Respiratory: Pharyngitis (7% to 9% )， Sinusitis (3% to 11% )， Upper respiratory infection (41% to 43% ) |
| 孕期建議   | No (limited) human data – animal data suggest low risk                                                                                                                                                                                                                                          |
| 哺乳期建議 | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                             |

